First Tracks Biotherapeutics Inc

NASDAQ: TRAX · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0002091349Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 50

v0.1 · 5/100 weight · pillars only

↑ market scale, workforce scale · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

104

as of 2026-09-02

Market cap

$1.4B

as of 2026-09-02

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is First Tracks Biotherapeutics Inc’s financial profile?

First Tracks Biotherapeutics Inc has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Tyra Biosciences, Inc.——Bicara Therapeutics Inc. Common Stock——Avalyn Pharma Inc. Common Stock——ArriVent BioPharma, Inc.——Latigo Biotherapeutics Inc.——Aktis Oncology, Inc.——

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B61C Sempra$12.4B63C DexCom, Inc.$4.7B87A ResMed Inc.$5.1B——Illumina, Inc.$4.3B84B+

Key facts

CEODaniel R. Faga

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: TRAX

Employees104

IPO date2026-04-20

Latest filings

10-Q2026-08-12 8-K2026-08-12 8-K2026-06-22 10-Q2026-05-14 8-K2026-05-14 8-K2026-04-20 8-K2026-04-03

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.